Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New tool for studying animal models of neurological and psychiatric diseases

05.11.2002


Will allow non-invasive study of neurochemistry, behavior, and disease progression



Scientists at the U.S. Department of Energy’s Brookhaven National Laboratory have demonstrated that a miniature positron emission tomography (PET) scanner, known as microPET, and the chemical markers used in traditional PET scanning are sensitive enough to pick up subtle differences in neurochemistry between known genetic variants of mice.

This "proof-of-principle" experiment, described in the November issue of the Journal of Nuclear Medicine, "opens up a whole new, non-invasive way to study and follow transgenic or genetically engineered strains of mice that serve as animal models for human neurological diseases, such as Parkinson’s and Alzheimer’s disease or psychiatric diseases such as substance abuse, depression, and anxiety disorders," said Panayotis (Peter) Thanos, lead author of the paper. Studying animal models may help scientists better understand and develop treatments for the human diseases.


Thanos and his team used microPET to measure the level of "D2" receptors for dopamine -- a brain chemical associated with feelings of reward and pleasure, which has been found to play a role in drug addiction -- in the brains of normal mice and so-called knockout mice, which had been genetically engineered to lack the gene for D2. The dopamine D2 receptor has been implicated in a wide variety of neuropsychiatric disorders, including, in recent studies by Brookhaven researchers, alcoholism and substance abuse. Thus, these D2-deficient mice are important for studying human diseases.

Before the scans, each mouse was given an injection of a radiotracer molecule designed to bind to D2 receptors. The microPET scanner then picked up the signal from the tracer to show where and how much was bound in various parts of the brain. The level of the tracer indicates the number of receptors.

In the striatum, a region of the brain normally rich in D2 receptors, "deficient" mice had significantly lower levels of tracer binding compared with their normal counterparts. There was no difference in tracer binding between strains in the cerebellum, an area of the brain that normally lacks D2 receptors, which was studied for comparison.

The scientists ruled out anatomical differences as a possible explanation for their results by comparing magnetic resonance imaging (MRI) brain scans of the two strains, which showed no differences. They also confirmed the difference in D2 receptor levels between "deficient" and normal mice with traditional autoradiography, where tissue samples are labeled with a radiotracer to reveal receptor levels.

"The results clearly show that microPET is an excellent technique that can pick up the neurochemical difference between the two strains in a non-invasive way," Thanos said. "And because this technique can be used in living animals, we can now study how these neurochemical differences between genetic strains of mice affect behavior and/or disease progression over time in the same animals," he said.

The technique can easily be extended to study other human neurological or psychiatric diseases for which knockout animal models exist, such as Alzheimer’s and Parkinson’s disease, or even depression and anxiety disorders.

This work was funded by the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, and the U.S. Department of Energy, which supports basic research in a variety of scientific fields.


The U.S. Department of Energy’s Brookhaven National Laboratory (http://www.bnl.gov) conducts research in the physical, biomedical, and environmental sciences, as well as in energy technologies. Brookhaven also builds and operates major facilities available to university, industrial, and government scientists. The Laboratory is managed by Brookhaven Science Associates, a limited liability company founded by Stony Brook University and Battelle, a nonprofit applied science and technology organization.

Note to local editors: Panayotis Thanos lives in Port Jefferson, New York.


Karen McNulty Walsh | EurekAlert!
Further information:
http://www.bnl.gov/

More articles from Health and Medicine:

nachricht Indications of Psychosis Appear in Cortical Folding
26.04.2018 | Universität Basel

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Why we need erasable MRI scans

New technology could allow an MRI contrast agent to 'blink off,' helping doctors diagnose disease

Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

European particle-accelerator community publishes the first industry compendium

26.04.2018 | Physics and Astronomy

Multifunctional bacterial microswimmer able to deliver cargo and destroy itself

26.04.2018 | Life Sciences

Why we need erasable MRI scans

26.04.2018 | Medical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>